transplantid.net

The Transplant Infectious Diseases #TxID Library for @AST_info @AST_IDCOP

[transplantid.net @TransplantIDNet]

The @ESCMID and @EANeurology guidelines on infectious encephalitis can be found at
GUIDELINES▶️📂ESCMID Guidelines
SYNDROMES▶️📁CNS

🚨Up front: ACV, MRI + contrast
🚨Pathogen-specific PCR more accurate than panels
🚨Repeat LP in 2-3 days if concerned

https://t.co/MuckZucUHF

[Prof Tom Solomon CBE @RunningMadProf]

Our European guidelines on diagnosing and managing infectious encephalitis in adults are now published in the European Journal of Neurology.

Thanks to all colleagues involved!

https://t.co/Oe74GN4xhy

#Encephalitis #Neurology

[Prof Tom Solomon CBE @RunningMadProf]

Our European guidelines on diagnosing and managing infectious encephalitis in adults are now published in the European Journal of Neurology.

Thanks to all colleagues involved!

https://t.co/Oe74GN4xhy

#Encephalitis #Neurology

[Shipra Goel @ShipraGoelMD]

Out now in @TheTxIDjournal , Cyclospora in transplant recipients during the 2026 multistate outbreak. Routine stool O&P misses it, so you have to order it specifically. Grateful to mentor Dr. Robin Avery for her guidance! #TxID #IDTwitter
https://t.co/Sjhp7H3L0I

[transplantid.net @TransplantIDNet]

Looking for a one-stop review of Chagas in immunocompromised patients?

This comprehensive Clinical Microbiology Reviews article has epidemiology, clinical manifestations,, treatment, and surveillance!

https://t.co/lhhPx6GxW2

[transplantid.net @TransplantIDNet]

Filed under
📂GUIDELINES▶️📁IDSA GUIDELINES &
📁ORGANISMS▶️📂FUNGI▶️📁Aspergillus

https://t.co/U2kQHlKTn1

Difficulty: few firm recommendations in the absence of robust data.
- some subpopulations of liver transplant which might benefit
- No re for or against in lung transplant

[IDSA @IDSAInfo]

New #IDSAGuidelines!

IDSA has released updated evidence-based recommendations on the prevention of invasive aspergillosis in adult solid organ transplant recipients: https://t.co/yYl8psAqN0

[transplantid.net @TransplantIDNet]

The American Academy of Pediatrics 2026 vaccine schedule is currently the gold standard.

Adding a new folder
📁GUIDELINES▶️📂AAP Guidelines
but also in the Vaccination folder, of course

https://t.co/4c2p3lkh50

[transplantid.net @TransplantIDNet]

Are many of you already using #fosfomycin to finish therapy for XDR cUTIs in your kidney transplant recipients?

Why or why not?

📁SYNDROMES AND CONDITIONS▶️📂UTI
https://t.co/6dbBVd8n7Z

[IDSA @IDSAInfo]

On IDSA’s & @HIVMA’s Science Speaks blog: A study in the International Journal of Infectious Diseases explored oral fosfomycin after carbapenems as de-escalating therapy in complicated UTIs.

Read IDSA’s Journal Club review by Aldon Li, MD, FIDSA.
https://t.co/Bd6CAS0Q9t

[transplantid.net @TransplantIDNet]

Of course to be found in https://t.co/2GHj3jMAOQ
Filed under
📁GUIDELINES▶️📂IDSA Guidelines
📁ORGANISMS▶️📂FUNGI▶️📂Aspergillus

https://t.co/U2kQHlLrcz

[IDSA @IDSAInfo]

New #IDSAGuidelines!

IDSA has released updated evidence-based recommendations on the prevention of invasive aspergillosis in adult solid organ transplant recipients: https://t.co/yYl8psAqN0

[transplantid.net @TransplantIDNet]

Just among the newest of the @AASLDtweets and @IDSAInfo guidelines added to https://t.co/2GHj3jMAOQ

📁GUIDELINES ▶️📂AASLD Guidelines
https://t.co/DabqRcDMJS

[AASLD @AASLDtweets]

AASLD brings critical resources and insights to our members to advance #liverdisease research, treatment, and care.

This #HepatitisAwarenessMonth, read, learn, and implement the #AASLD & @IDSAInfo Practice Guideline on the Treatment of Chronic #HepatitisB.

From prevention and maternal transmission to treatment strategies and #livercancer surveillance, get the latest evidence-based recommendations to guide care across every phase of chronic hepatitis B.

📗Online in @HEP_Journal: https://t.co/EqznLgtl1G

[transplantid.net @TransplantIDNet]

As @AHAScience continues to update guidelines for 🫀endovascular infections, you can find them at https://t.co/2GHj3jMAOQ!

📁GUIDELINES ▶️📂AHA Guidelines
https://t.co/GDcuFyYYpt

[LBaddour @LBaddour1]

Infective Endocarditis: Diagnosis, Antibiotic Therapy, and Management: A Scientific Statement From the American Heart Association | Circulation https://t.co/x5gB7OpKl7
❤️‍🔥 Congratulations Dan and colleagues. #AHA @MayoClinicINFD @MayoClinicCV

[transplantid.net @TransplantIDNet]

Is it time to stop using nitazoxanide for norovirus?

ORGANISMS▶️VIRUSES ▶️Norovirus

What else is left?

https://t.co/JcSMdfWBIY

[American Journal of Transplantation @amjtransplant]

New from AJT: Boutin et al. report phase 2 findings on nitazoxanide for norovirus in hematopoietic stem cell and solid organ transplant recipients.

Read now: https://t.co/mCRxU9VBCK

#Norovirus #Transplantation #Nitazoxanide

[transplantid.net @TransplantIDNet]

You can also find the "Surviving Sepsis" guidelines under

📂GUIDELINES ▶️📁@SCCM

Also endorsed by @IDSAInfo !

Adult: https://t.co/7lVBV7mYJi
Pediatric: https://t.co/IRtad5lsfj

[SCCM @SCCM]

NEW: Review the latest updates to the Surviving Sepsis Campaign Guidelines for Sepsis and Septic Shock.
Adult Guidelines: https://t.co/RIwH7dKOXR
Children's Guidelines: https://t.co/wRcKzgU5A9

@critcaremed @pedcritcaremed #SCCM #SCCM2026

[transplantid.net @TransplantIDNet]

@IDSAInfo is keeping a dynamic update online to the new Histo guidelines!

At https://t.co/2GHj3jMAOQ
📁IDSA guidelines &
📁FUNGI ▶️📂Dimorphic mycoses

Thanks to our 🍄🌟🌟including @stoverkr @DrNevBadreldin @DrPappasID

https://t.co/FM7S7opB5p

[IDSA @IDSAInfo]

IDSA has released a new consensus statement on initial antifungal treatment of severe histoplasmosis in adults, children, and pregnant individuals: https://t.co/lZNCPAFdYM

[transplantid.net @TransplantIDNet]

As https://t.co/2GHj3jM2Zi comes back, we are updating our @IDSAInfo and @ESCMID guidelines!

More uniform recommendations:
- TTE - everyone
- follow-up blood cx strategy
- duration of therapy

https://t.co/zhBl5njRnD

[IDSA @IDSAInfo]

IDSA and @ESCMID have released Part 1 of new consensus statements for Staphylococcus aureus bacteremia, introducing a risk-based approach to support diagnostic evaluation and more individualized treatment decisions.

📄: https://t.co/Vno6NwFuZM

[Raymund Razonable @RazonableMD]

Refractory, resistant and recurrent CMV after SOT: risk factors and clinical outcomes
@ZYetmar @MayoClinicINFD @MayoTransplant
https://t.co/6vyfDenhcs

[IDSA @IDSAInfo]

NEW #IDSAGuidelines! For the 2025-2026 respiratory season, IDSA strongly recommends age-appropriate COVID-19 vaccinations for immunocompromised adults and children: https://t.co/aUWY8u43Tx

[transplantid.net @TransplantIDNet]

@IDSAInfo 2025 Guidelines on the Use of Vaccines for the Prevention of Seasonal COVID-19, Influenza, and RSV Infections in Immunocompromised Patients

https://t.co/RzIv69FTGb

[DrDemetre @dr_demetre]

This is the season to get vaccinated for the big three respiratory viruses: #Flu, #COVID, and #RSV. Who needs what?

-Flu: Everyone 6 months +

-RSV: Everyone 75yo+ and 50-74yo at higher risk. Also, get it in pregnancy to prevent RSV in your newborn. If not, give injected antibodies (monoclonal antibodies) for newborns whose moms didn’t get vaccinated against RSV in pregnancy.

-COVID-19: ask your provider AND remember 6m-23m and 65yo+ are at high risk and should get it. 24m-64yo w risk factors too (including pregnancy)

Make these infections go from WILD TO MILD. Vaccines can prevent infection or make infection less severe! This is how you RISK LESS TO DO MORE with your family and friends!

[Joanna Schaenman MD PhD @jschaenman]

Highway to the donor danger zone? Please join the #TxID crew Tues 8am in B312 for 'Should I Take This Donor?' 🤔 w donor-derived infx experts @StephaniePouch and @EmilyBlumbergMD dropping knowledge on all your donor-related q's ♥️ 🫁 🫘 @AneeshMehtaMD @IDWeekmtg #IDWeek2025

[transplantid.net @TransplantIDNet]

Counseling immunocompromised patients on minimizing 🆔 risks? Don't reinvent the 🛞!

@AST_info @AST_IDCOP has @ThePower2Save Safer Living Patient Information sheets! Translations and more topics in upcoming years!

https://t.co/p7IyYz903o